Advertisement
Advertisement
VRNA
Verona Pharma plc
63.40
USD+1.39
+2.25%
Apr 23, 16:00 UTC -4
Closed
After-Market
64.38
+0.97
+1.53%
Verona Pharma plc Profile
About
Info & Links
CEO
David Zaccardelli
Headquarters
LONDON, X0 SE1 2RE, UNITED KINGDOM
Industry
Sector
Website
Auditor
Ernst & Young LLP
Share holders
--
Employees
209
Verona Pharma plc Statistics
Valuation Measures
Market Capitalization2
5.47B
Enterprise Value
5.19B
Enterprise Value/EBITDA(ttm)
-34.11
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
40.25
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
46.20%
Operating Margin(ttm)
--
Profit Margin(ttm)
-214.05%
Return on Equity(ttm)
-79.54%
Return on Invested Capital(ttm)
-61.32%
Return on Assets(ttm)
-43.49%
Income Statement
Revenue(ttm)
42.28M
Revenue Per Share(ttm)
0.50
Gross Profit(ttm)
39.70M
EBITDA(ttm)3
-152.26M
Net Income Available to Common(ttm)
-173.42M
Diluted EPS(ttm)
-1.92
Share Statistics
Beta (5Y Monthly)
0.41
52-Week Change
303.33%
S&P 500 52-Week Change
6.02%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
84.98M
Dividend Yield
0.00%
Float4
76.10M
% Held by Insiders
4.80%
% Held by Institutions
85.88%
Balance Sheet
Total Cash(mrq)
399.76M
Total Cash Per Share(mrq)
4.70
Total Debt(mrq)
120.34M
Total Debt/Equity(mrq)
58.83%
Current Ratio(mrq)
10.63%
Quick Ratio(mrq)
12.88%
Book Value Per Share(mrq)
2.42
Cash Flow
Operating Cash Flow Per Share(ytd)
-1.50
Free Cash Flow(ytd)
-122.78M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement